Country: United States
Language: English
Source: NLM (National Library of Medicine)
POTASSIUM CHLORIDE (UNII: 660YQ98I10) (POTASSIUM CATION - UNII:295O53K152)
Contract Pharmacy Services-PA
POTASSIUM CHLORIDE
POTASSIUM CHLORIDE 10 meq
ORAL
PRESCRIPTION DRUG
BECAUSE OF REPORTS OF INTESTINAL AND GASTRIC ULCERATION AND BLEEDING WITH EXTENDED-RELEASE POTASSIUM CHLORIDE PREPARATIONS, THESE DRUGS SHOULD BE RESERVED FOR THOSE PATIENTS WHO CANNOT TOLERATE OR REFUSE TO TAKE LIQUID OR EFFERVESCENT POTASSIUM PREPARATIONS OR FOR PATIENTS IN WHOM THERE IS A PROBLEM OF COMPLIANCE WITH THESE PREPARATIONS. - For the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitais intoxication and in patients with hypokalemic familial periodic paralysis. If hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. - For the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, e.g., digitalized patients or patients with significant cardiac arrhythmias. The use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patients have a
Potassium Chloride Extended-release Tablet, USP, 1500 mg of potassium chloride (20 mEq of potassium) are available in: Potassium Chloride Extended-release Tablets, USP 20 mEq are white, oblong, imprinted US 20 and scored for flexibility of dosing. Potassium Chloride Extended-release Tablet, USP, 750 mg of potassium chloride (10 mEq of potassium) are available in: Potassium Chloride Extended-release Tablets, USP 10 mEq are white, oblong imprinted US 10.
Abbreviated New Drug Application
POTASSIUM CHLORIDE- POTASSIUM CHLORIDE TABLET, EXTENDED RELEASE CONTRACT PHARMACY SERVICES-PA ---------- POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS, USP MICROENCAPSULATED DESCRIPTION Potassium Chloride Extended-release Tablets, USP are an immediately dispersing extended-release oral dosage form of potassium chloride containing 1500 mg of microencapsulated potassium chloride, USP equivalent to 20 mEq of potassium in a tablet. Potassium Chloride Extended-release Tablets, USP are an immediately dispersing extended-release oral dosage form of potassium chloride containing 750 mg of microencapsulated potassium chloride, USP equivalent to 10 mEq of potassium in a tablet. These formulations are intended to slow the release of potassium so that the likelihood of a high localized concentration of potassium chloride within the gastrointestinal tract is reduced. Potassium Chloride Extended-release Tablets, USP is an electrolyte replenisher. The chemical name of the active ingredient is potassium chloride, and the structural formula is KCl (molecular weight: 74.55). Potassium Chloride, USP occurs as a white, granular powder or as colorless crystals. It is odorless and has a saline taste. Its solutions are neutral to litmus. It is freely soluble in water and insoluble in alcohol. Potassium Chloride Extended-release Tablets, USP is a tablet formulation (not enteric coated or wax matrix) containing individually microencapsulated potassium chloride crystals which disperse upon tablet disintegration. In simulated gastric fluid at 37°C and in the absence of outside agitation, Potassium Chloride Extended-release Tablets, USP begins disintegrating into microencapsulated crystals within seconds and completely disintegrates within one minute. The microencapsulated crystals are formulated to provide an extended release of potassium chloride. Inactive Ingredients: croscamellose sodium, ethylcellulose and microcrystalline cellulose. CLINICAL PHARMACOLOGY The potassium ion is the principal intracellular cation of most body tissues. Pota Read the complete document